NCT00426764 2020-02-11
A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
Celgene
Phase 2 Completed
Clinical Trials
6 trialsNCT00765102 2019-11-25
Trial of Romidepsin and Bortezomib for Multiple Myeloma
Celgene
Phase 2 Terminated
NCT00106301 2019-11-18
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228
Celgene
Phase 2 Completed
NCT00106418 2019-11-18
A Research Study for Patients With Prostate Cancer
Celgene
Phase 2 Completed
NCT00106431 2019-10-30
A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)
Celgene
Phase 2 Completed
NCT00106613 2019-10-18
A Research Study for Patients With Metastatic Renal Cell Carcinoma
Celgene
Phase 2 Completed